LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.310
+0.005 (0.38%)
At close: Jun 27, 2025, 4:00 PM
1.320
+0.010 (0.76%)
After-hours: Jun 27, 2025, 4:04 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $34.46 million as of June 27, 2025. Its market cap has decreased by -43.75% in one year.
Market Cap
34.46M
Enterprise Value
-31.79M
1-Year Change
-43.75%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $34.46M, a decrease of -90.94%. That is a compound annual growth rate of -43.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 34.46M | 37.78% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |